This article is more than 5 years old. Information may no longer be current.
Research highlights progress of PROMISE, controversies in treatment of chronic angina
Click Here to Manage Email Alerts
New-onset stable chest pain or angina in those without diagnosed heart disease affects about 4 million Americans per year. In response, the editors of Cardiology Today have compiled an interactive online supplement that provides the most recent research available on patients with this complex cardiac disorder.
In the supplement, key opinion leaders share their insights on the PROMISE trial, which generated numerous conversations and many questions within the cardiology community. Results from the SCOT-HEART trial, which examined the use of CT coronary angiography in this population, include a perspective from Carl J. Pepine, MD, Chief Medical Editor of Cardiology Today. The role of CT-derived fractional flow reserve data in the management of angina and the impact of smoking on post-MI outcomes are also reviewed, as well as research regarding the effect of a coronary-sinus reducing device in this population. Click here to view the interactive pdf, and visit Healio.com/Cardiology for daily breaking headlines in the specialty.
